Schedule 13G ownership disclosure

CERVOMED INC

Common Stock · CUSIP: 15713L109

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Morgan Stanley

    Shares: 473,681 · Class: 5.1%

  • Morgan Stanley Capital Services LLC

    Shares: 470,631 · Class: 5.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000895421-26-000035
Form type
SCHEDULE 13G
Filer
CervoMed Inc.
CIK
CIK 1053691
Filed
Feb 11, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub